• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations

Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations

Hardcover

Series: Chapman & Hall/CRC Biostatistics

Medical ReferenceGeneral PsychologyProbability & Statistics

ISBN10: 1032136553
ISBN13: 9781032136554
Publisher: CRC Press
Published: May 23 2024
Pages: 458
Weight: 2.34
Height: 1.06 Width: 7.00 Depth: 10.00
Language: English

One of the recent advances in 21st century medicine is the emergence of gene therapies, drugs that affect the basic biology of genetic disease. The field has seen some notable setbacks in the past, but in recent years has exploded as decades of basic science have been successfully translated into the most complex biologics ever constructed, leading to regulatory approval of several gene therapy products in oncology, hematology, neurology, and ophthalmology indications. These drugs are at the apex of biological manufacturing complexity, and have the potential to be disease modifying or even curative. Evidence-based and innovative quantitative clinical development and lifecycle management strategies will be required as fixtures in the development for these unique drugs in order to reach patients in need.

Also in

Probability & Statistics